Bioengineering policy and strategy piece arguing for three priority changes to boost Europe’s research, education and innovation ecosystems.
Key Takeaways
- Vasilis Ntziachristos Vasilis Ntziachristos is chair of biological imaging at the Technical University of Munich
- Bioengineering can produce tools for use in cutting-edge cell therapies, among other applications
- Investment in medical technologies in the EU27 is low (see ‘Untapped potential’)